Skip to main content
. 2022 Mar 17;27:21. doi: 10.4103/jrms.jrms_1390_20

Table 3.

The statistical indicators of breast cancer screening

First author/city/year of publication Study design Study population Sample size Mean age (SD) Reported index The most important findings
Taymoori, Sanandaj, 2009[112] Cross-sectional Employed females in governmental institutes and departments 606 37.08 (9.81) Instrument Developing and validating CHBMS to assess Iranian females’ beliefs related to BC and screening
Barfar, 10 cities of Iran, 2014[109] Cost-effectiveness Females >35 years 26,606 NA Detection rate Detection rate: 24 per 100,000
The cost per cancer detected:$15,742
False-positive detection rate: 7.5%
Miller, Yazd, 2015[106] Field-trial Females residing in urban areas 12,602 NA Response rate to BSE + CBE screening of BC Response rate: Data collection at patients’ homes in both groups: 100%
Visiting HCC in the intervention group: 84.5%
Jafari, Kerman, 2015[106] Cross-sectional Females 35-69 years 15,794 NA Participation rate Participation rate: Urban region 3.8%, villages and towns 16.34%
Saghatchi, Zanjan, 2015[107] Cross-sectional Females admitted to the mammography center of Mousavi Hospital 526 44.3 Detection rate
Abnormality rate
Screening mammography rate: 27.4%
Diagnostic sonography rate: 26%
Biopsy rate: 1.4%
Detection rate: 2.3%
Abnormality rate: 33%
Khazaee_Pool, Tehran, 2016[113] Cross-sectional Females referred to TUMS HCCs 585 41.25 (6.34) Instrument Developing and validating an instrument to identify factors affecting females’ BC prevention behaviors named ASSISTS
Aminisani, Baneh, 2016[52] Cross-sectional Females >40 years referred to HCCs 561 43.64 (5.17) Participation rate Participation rate in mammography program: 16.8%
The lowest level of participation: Females >60 years, illiterate, postmenopausal
Shafaie, Tabriz, 2016[110] Cross-sectional Females referred for screening to BC clinic of Behbood Hospital 5000 37.45 (10.81) Abnormal finding rate After CBE: 759 abnormal cases
After 996 sonography: 40 abnormal cases
After 636 mammography: 183 abnormal cases
After 14 FNA: One cancer case (7.1%)
Moshki, Sanandaj, 2017[114] Cross-sectional Females referred to HCCs in Sanandaj 482 47.35 (9.8) Instrument A valid instrument for mammography self-efficacy and fear of BC scales in Iranian women
Alikhassi, Tehran, 2017[108] Longitudinal Females referred to a university hospital 9395 49.84 (9.19) Recall rate, detection rate of opportunistic screening mammography Recall rate: total: 24.7%, first mammography: 29%, subsequent Mammography: 22%, micro-calcification: 21.1%, mass: 49.3%, distortion: 34.8%, asymmetry: 48.1%
Cancer detection rate: 8.5 per 1000 mammography
Poorolajal, Tehran, 2018[115] Cross-sectional Native Iranian women 1422 Intervention 48.37 (10.79)
Control 42.37 (9.84)
Instrument Age alone is not a strong predictor of BC
The chart: facilitates making decisions on the threshold for recommending screening mammography, detects high-risk individuals
Khazaee_Pool, Sanandaj, 2018[116] Cross-sectional Females referred to HCCs in Sanandaj 434 48.12 (8.91) Instrument Response rate: 91%
A valid instrument: MSS
Pourhaji, Tehran, 2018[117] Cross-sectional Females >40 years referred to HCCs of SBMU 200 Median (45.6) Model A valid instrument: BSEBPS
Heidari, Isfahan, 2018[118] Cross-sectional Persian language females 1078 36.5 (11.65) Instrument Transcultural adaptation and validation of an instrument: BCAM
Fathollahi_Dehkord, Isfahan, 2018[101] Clinical-trial Females with a BC_FH 98 Intervention 36.04 (10.90)
Control 35.58 (10.22)
Response rate to CBE screening Response rate: 81%
Khazaee-Pool, Tehran, 2018[119] Cross-sectional Females 30-75 years referred to HCCs of TUMS 260 45.12 (5.92) Model Seven constructs of model: Perceived social support, attitude, motivation, self-efficacy, information seeking, stress management, self-care
A, motivation, self-efficacy, information seeking, social support influence self-care behavior and stress management
Saei Ghare Naz, Tehran, 2019[111] Cross-sectional Females referred to HCCs of SBMU 325 34.82 (11.73) BCSB and MHLC score BCSB: 40.72±10.41 MHLC: 67.78±17.67

SD=Standard deviation; TUMS=Tehran University of Medical Sciences; HCC=Health Care Center; BC=Breast cancer; SBMU=Shahid Beheshti Medical University; BC_FH=Family history of breast cancer; BSE=Breast self-examination; CBE=Clinical breast examination; NA=Not available; BCSB=Breast cancer screening belief; MHLC=Multidimensional health locus of control; CHBMS=Champion Health Belief Model Scale; FNA=Fine-needle aspiration; MSS=Mammography social support; BSEBPS=Breast Self-Examination Behavior Predicting Scale; BCAM=Breast cancer awareness measure